2021 - 2024 | mobio.org

2024

SB 751 and HB 340 B Group Letter -4/20/24

HB 2763 B Support Letter -3/7/24

2023

Medicaid Program; Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program [CMS-2434-P] -10/19/2023

S tate Of Medical Technolog y Alliance -8/28/2023

Request for Action on Medical Research Matter; Nonhuman Primate Model Crisis - 3/15/2023

2022

O pposition to WTO TRIPS Waiver To Include Vaccines, and COVID-19 Therapeutics and Diagnostics - 10/25/2022

Congressional Leadership Expressing Strong Concerns Over Senate Democrats’ Drug Pricing Proposals Letter - 0 7/30/2022

S tand With Missou ri Patients Against Government Interference - 0 7/26/2022

Medicare and RX Access Network Missouri Urges Congress To Reauthorize The Prescription Drug User Fee Act (PDUFA) - 0 5/26/2022

General Assembly Invests Heavily In MTC Update - 0 5/13/2022

Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Letter - 0 5/09/2022

2021

Mexico Measures on Agricultural Biotechnology Letter - 11/17/21

Q ualified Small Business Stock (QSBS) Letter - 10/29/21

Multi-Cancer Early Detection Coverage Act - 8/27/21

A Declaration from Members of the World’s Biotechnology Sector On Global Access to COVID Vaccines & Treatments and the Role of Intellectual Property - 6/10/21

Republican Governors Association Summit - 6/2/21

Missouri HR3 Statement of Opposition Letter - 5/28/2021